Intuitive Surgical

  • Why Investors are Bullish on Mazor Robotics

    By George Budwell - August 26, 2013 | Tickers: ISRG, MAKO

    One of the best strategies to earn market-beating returns is to invest in companies possessing ground-breaking technologies that have yet to be discovered by the broader market. The medical robotic company Mazor Robotics (NASDAQ: MZOR) is the maker of the state-of-the-art spinal surgery system Renaissance™, which enables surgeons to conduct spine surgeries in an accurate and secure manner. Although the system has been commercially available since 2010, physicians are only more »

  • Satiate Your Lust for Bucks With These Healthcare Players

    By Narmin Jiwani - August 15, 2013 | Tickers: ABT, ISRG, MDT

    Mankind can’t do without healthcare; we know that; it’s a criminally bare story. Very few industries touch human lives the way healthcare industry does. And, when you consider the growth of the industry which supplies medical devices to the hospitals, the story becomes even more compelling. According to Lucintel, global medical device industry is expected to grow at a CAGR of 6.1% in a six-year period initiating more »

  • Are Huge Share Buybacks Enough to Lift These Struggling Stocks?

    By Bob Ciura - August 7, 2013 | Tickers: CAT, ISRG, POT

    When companies fall on hard times, investors often look for any reason for optimism they can find. Management teams, hoping to buoy investors’ spirits, often resort to share buybacks to boost morale and to build a floor underneath the stock price.

    That’s exactly the tactic being employed by these three companies, whose businesses have stagnated in recent months and taken their stock prices down in tandem.

    Are new, generous more »

  • Do Recent Declines in These Stocks Offer Opportunities for Profit?

    By Rupert Hargreaves - August 2, 2013 | Tickers: CROX, HTS, ISRG

    I like to look for undervalued companies by searching for stocks that have put in the worst performances over the past week or month. However, it is not always that easy, as some companies have further to fall and there's no thesis for a long-term investment. So how do some of the biggest decliners this month stand up to analysis?

    First up, then down 24% this month

    Intuitive Surgical more »

  • Is a Huge Share Buyback The Cure For This Healthcare Stock?

    By Bob Ciura - July 31, 2013 | Tickers: ISRG, JNJ, MAKO

    Beleaguered healthcare stock Intuitive Surgical (NASDAQ: ISRG) recently announced a new, massive share repurchase authorization. The buyback couldn’t come at a better time. The stock is reeling after a hugely disappointing quarterly report and widespread fears about the safety of its revolutionary da Vinci surgical robots.

    Should investors take this news seriously? Or is management simply trying to buy itself time until it can sort out its underlying problems more »

  • Intuitive Surgical: Is Growth Over?

    By Jason Bond - July 31, 2013 | Tickers: ISRG, IRBT, MAKO

    Intuitive Surgical (NASDAQ: ISRG), the industry leader in robotic assisted surgery, has come a long way from its founding in 1995 and IPO in 2000. It has gone from a $9 IPO in 2000 all the way to $500 per share earlier this year. Now that the stock has fallen back below $400, is the stock a buy, hold, or sell?

    The product

    There is no doubt that Intuitive Surgical more »

  • Lucrative Healthcare Stocks for Your Portfolio

    By Nihar Patel - July 23, 2013 | Tickers: ISRG, IRBT, MCK

    The healthcare industry faces major political headwinds, but demographics are a far more powerful force in the long-term. Political regimes only last for a few years in the United States, but demographics have trajectories that play out as expected over decades. For healthcare, an aging population is a strong overarching force that will drive revenue for years to come.

    As people live longer, they will require more care, more surgery more »

  • This Health Care Stock Is Rapidly Approaching Buy Territory

    By Bob Ciura - July 22, 2013 | Tickers: ISRG, JNJ, MAKO

    Health-care stock Intuitive Surgical (NASDAQ: ISRG) used to be a favorite among growth investors just a few quarters ago. The company grew sales and profits at double-digit rates like clockwork and had a soaring share price reflecting its outstanding results.

    All that has changed, and the good times seem like an eternity ago. The company’s newly released quarterly results confirmed what investors had feared about the state of its more »

  • Left and Right Handed Investing

    By J.A. Graham - July 22, 2013 | Tickers: ISRG, NFLX, TSLA

    There are two types of investors—those who love a great bargain and those who love a great story. Ok, that’s probably a simplification and there are a few more breeds, but value and growth stories seem to be one of the more polarizing dichotomies in the investment world.

    Nothing makes a value investor happier than a stock smacked down by the market, selling at bargain basement prices and more »

  • Is This Gloomy Warning a Telltale Sign for the Medical Devices Industry?

    By Ryan Guenette - July 17, 2013 | Tickers: BAX, BDX, ISRG, MDT

    On July 9, Intuitive Surgical (NASDAQ: ISRG) warned of second-quarter financial results coming in at disappointing levels, although the company does not officially report until July 18.

    The company stated that it expects sales to come in at $575 million for the second quarter, nearly 9% south of the consensus of Wall Street analysts. Year over year, growth is still anticipated to top 7%; however, it will be the first more »

  • Has Intuitive Surgical's Stock Been Fairly Slashed Down?

    By Michael Carter - July 15, 2013 | Tickers: BBRY, GMCR, ISRG

    Do the words lackluster, plunges, slumps, or weak define $575 million in net revenues for a quarter? Well, apparently they do according to Wall Street analysts following Intuitive Surgical (NASDAQ: ISRG) after the designer and manufacturer of the da Vinci Surgical Systems line of medical instruments gave a lower than expected outlook last week. Its guidance falls below the $630 million expected from Wall Street, even though it is still more »

  • Can This Robot Doctor Heal Itself?

    By Leo Sun - July 12, 2013 | Tickers: ARAY, ISRG, MAKO | Editor's Choice

    Shares of surgical robot maker Intuitive Surgical (NASDAQ: ISRG) plunged 16% on July 9, after the Sunnyvale, Calif.-based company warned that its second quarter revenue would come in below analyst estimates when it reports earnings on July 18.

    It’s been a chaotic year for Intuitive Surgical, which produces the da Vinci surgical robot that was once the darling of Wall Street. Despite rising 2,700% over the past more »

  • Is Intuitive Surgical Cheap After the Recent Plunge?

    By Anh HOANG - July 11, 2013 | Tickers: ARAY, ISRG, MDT

    Recently, Intuitive Surgical (NASDAQ: ISRG) experienced a significant decline of more than 11.3% in after-hours trading, from $500 per share to only $443.50 per share. The dramatic fall was due to its disappointing outlook for its second quarter results. Should investors consider this recent significant drop a buying opportunity? Let’s take a closer look and find out.

    Fast and consistent operating performance growth

    Intuitive Surgical is the more »

  • What Is Missed on Intuitive Surgical's Big Miss

    By Dana Blankenhorn - July 11, 2013 | Tickers: ARAY, ISRG, MAKO | Editor's Choice

    Investors got little warning on Intuitive Surgical's (NASDAQ: ISRG) big second quarter miss. The first most heard about it might have been the company's own press release – the company doesn't officially report until next week.

    In practical terms the miss isn't much – revenue of $575 million against an expected $630 million, and net income of $160 million instead of $177.7 million. But the stock, which more »

  • This Health Care Stock Isn't Out of the Woods

    By Bob Ciura - July 10, 2013 | Tickers: ISRG, JNJ, MAKO

    Over the past year, Intuitive Surgical (NASDAQ: ISRG) has been mired in a mix of controversy pertaining to the safety of its revolutionary da Vinci surgical robots. Reports first leaked throughout the media questioning the safety of the company’s surgical systems. In fact, CNBC did a detailed report that brought the issue to the forefront of the financial media.

    At the time, those fears were not yet substantiated. It more »

  • Big Growth Opportunities for 3 Medical Equipment Makers

    By Madhukar Dubey - June 28, 2013 | Tickers: ISRG, MDT, SYK

    Some diseases cannot be cured by traditional drugs but instead require a surgical procedure. This is one of the reasons for constant and increasing demand for medical equipment. The global market for medical equipment is expected to increase at a compound annual growth rate of 7.1% from $307.7 billion in 2012 to $434.4 billion by 2017. In order to monetize this opportunity, the medical equipment manufacturing companies more »

  • A Regular Fool's Retirement Portfolio: Razors, Bubbles and Robot Doctors

    By Jason Hall - June 26, 2013 | Tickers: ISRG, MAKO, SODA

    I've identified a handful of companies that use the so-called "razor and blades" model to deliver predictable, long-term results. Some are just starting, some have a sustained record of success. But all of them are part of my retirement portfolio, which means I'm hoping to hold them forever. Go here to see how I'm doing. Will you learn more from my successes or my inevitable mistakes? 

    Razors more »

  • Insights From Lone Pine Capital’s Portfolio

    By Aubrey Tabuga - June 26, 2013 | Tickers: ISRG, MJN, MDT

    It is always interesting to peer into the transactions of large asset managers such as Lone Pine Capital. The fund manager had a whopping $19.3 billion assets under management as of the latest quarter (based on whalewisdom compilation). I looked into its 13F filings to extract some investment ideas, and two of its big buys caught my attention. Lone Pine increased its position in Mead Johnson Nutrition (NYSE: MJNmore »)

  • Dreaming of Robot Doctors and Electric Cars

    By Leo Sun - June 18, 2013 | Tickers: ISRG, IRBT, TSLA

    In investing, the greatest advantage an investor can have is a long-term investment horizon. Warren Buffett once said, “The stock market is designed to transfer money from the active to the patient.”

    Therefore, true long-term investors, who are dedicated to holding stocks for decades, not months, should consider visionary companies that will shape the future of humankind. In this article, I’ll discuss three cutting edge companies that are more »

  • Robots for the Future

    By Nihar Patel - June 17, 2013 | Tickers: ISRG, IRBT

    The last time I wrote about Intuitive Surgical (NASDAQ: ISRG), I devoted myself to dispelling false fears and shifting the focus to potential issues that could arise in an FDA probe. I now realize that there are a couple of issues that could further weigh on the company's share price.

    Probes can find too much

    When a company is subject to regulatory oversight, the regulatory agency has the right more »

  • Page 1 of 6